Can-Fite BioPharma Ltd. (TLV:CANF)

Can-Fite BioPharma Statistics

Total Valuation

TLV:CANF has a market cap or net worth of ILS 21.79 million. The enterprise value is -5.21 million.

Market Cap	21.79M
Enterprise Value	-5.21M

Important Dates

The next estimated earnings date is Wednesday, August 26, 2026.

Earnings Date	Aug 26, 2026
Ex-Dividend Date	n/a

Share Statistics

TLV:CANF has 4.29 million shares outstanding. The number of shares has increased by 126.97% in one year.

Current Share Class	4.29M
Shares Outstanding	4.29M
Shares Change (YoY)	+126.97%
Shares Change (QoQ)	+89.50%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	2.24%
Float	4.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.88
PB Ratio	1.22
P/TBV Ratio	1.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.17
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.18

Financial Position

The company has a current ratio of 3.46, with a Debt / Equity ratio of 0.01.

Current Ratio	3.46
Quick Ratio	3.13
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -178.24% and return on invested capital (ROIC) is -111.02%.

Return on Equity (ROE)	-178.24%
Return on Assets (ROA)	-66.75%
Return on Invested Capital (ROIC)	-111.02%
Return on Capital Employed (ROCE)	-146.69%
Weighted Average Cost of Capital (WACC)	3.66%
Revenue Per Employee	258,228
Profits Per Employee	-6.27M
Employee Count	5
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.08% in the last 52 weeks. The beta is -0.10, so TLV:CANF's price volatility has been lower than the market average.

Beta (5Y)	-0.10
52-Week Price Change	-91.08%
50-Day Moving Average	661.50
200-Day Moving Average	2,427.54
Relative Strength Index (RSI)	37.41
Average Volume (20 Days)	33,155

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TLV:CANF had revenue of ILS 1.29 million and -31.33 million in losses. Loss per share was -19.03.

Revenue	1.29M
Gross Profit	1.29M
Operating Income	-31.72M
Pretax Income	-31.33M
Net Income	-31.33M
EBITDA	-31.64M
EBIT	-31.72M
Loss Per Share	-19.03

Balance Sheet

The company has 27.23 million in cash and 226,348 in debt, with a net cash position of 27.00 million or 6.30 per share.

Cash & Cash Equivalents	27.23M
Total Debt	226,348
Net Cash	27.00M
Net Cash Per Share	6.30
Equity (Book Value)	17.83M
Book Value Per Share	6.81
Working Capital	21.39M

Cash Flow

In the last 12 months, operating cash flow was -28.53 million and capital expenditures -6,376, giving a free cash flow of -28.54 million.

Operating Cash Flow	-28.53M
Capital Expenditures	-6,376
Depreciation & Amortization	75,009
Net Borrowing	n/a
Free Cash Flow	-28.54M
FCF Per Share	-6.66

Margins

Gross Margin	100.00%
Operating Margin	-2,456.79%
Pretax Margin	-2,426.67%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TLV:CANF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-126.97%
Shareholder Yield	-126.97%
Earnings Yield	-143.76%
FCF Yield	-130.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 5, 2026. It was a reverse split with a ratio of 0.0003333333.

Last Split Date	Jan 5, 2026
Split Type	Reverse
Split Ratio	0.0003333333

Scores

TLV:CANF has an Altman Z-Score of -26.02 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-26.02
Piotroski F-Score	1